ClinicalTrials.gov
public full text
Public Domain
A Single-dose Study of Octreotide Injection in Healthy Adult Subjects
This is a single-centre, single-dose, dose-escalation, placebo and positive drug-controlled Phase I clinical study in healthy Chinese subjects to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profile of octreotide injection in healthy Chinese subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers#813602
- DELIVERY STRATEGIES FOR OLIGONUCLEOTIDE-BASED THERAPIES#929277
- Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors#884305
- A Trial of Ipatasertib in Combination With Atezolizumab#1100759
- Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers#867606
Record · ID 825700
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive